Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 16901-16950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03241706
Liver Glycogen and Hypoglycemia in Humans
PHASE1Active, not recruiting
40 participants
Started: Aug 2, 2018 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT03610737
The MOTION Study - Treatment of LSS With the MILD Procedure
NAActive, not recruiting
155 participants
Started: Aug 2, 2018 · Completed: Apr 30, 2025
1 condition1 sponsor18 locations
NCT03853655
Adjuvant Radiotherapy in Early Stage Oral Cancers
NAActive, not recruiting
392 participants
Started: Aug 2, 2018 · Completed: Sep 30, 2026
5 conditions2 sponsors8 locations
NCT03523546
Oncology Episode Payment Model in Hawaii
NAActive, not recruiting
7 participants
Started: Aug 1, 2018 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT03523585
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
PHASE3Active, not recruiting
608 participants
Started: Aug 1, 2018 · Completed: Jul 31, 2025
1 condition3 sponsors227 locations
NCT03605550
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
PHASE1Active, not recruiting
64 participants
Started: Aug 1, 2018 · Completed: Mar 1, 2029
2 conditions2 sponsors10 locations
NCT03385655
Prostate Cancer Biomarker Enrichment and Treatment Selection
PHASE2Active, not recruiting
200 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2025
1 condition3 sponsors11 locations
NCT03868384
The Effect of Home Blood Pressure Measurement on the Management of Hypertension
N/AActive, not recruiting
701 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04814355
The Effect of Celecoxib on Neuroinflammation in MDD
PHASE4Active, not recruiting
42 participants
Started: Aug 1, 2018 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT03430401
Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia
NAActive, not recruiting
60 participants
Started: Aug 1, 2018 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT03620578
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL
PHASE2Active, not recruiting
97 participants
Started: Aug 1, 2018 · Completed: Oct 31, 2026
5 conditions1 sponsor24 locations
NCT03563131
Tibial and Femoral Components Migration and Adaptive Bone Remodeling After Insertion of Persona® TKA
NAActive, not recruiting
66 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03626103
Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents
NAActive, not recruiting
800 participants
Started: Aug 1, 2018 · Completed: Feb 28, 2025
2 conditions2 sponsors2 locations
NCT03924830
Influence of Surface Sealants on the Quality of Posterior Restorations With Bulk Fill Composites
NAActive, not recruiting
53 participants
Started: Aug 1, 2018 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT03604302
Evaluation of Preoperative Functional Magnetic Resonance Imaging (fMRI) in Patients With Brain Tumors
NAActive, not recruiting
33 participants
Started: Aug 1, 2018 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT03041610
Pedometer-Based Walking Intervention in Patients With Chronic Heart Failure With Reduced Ejection Fraction
NAActive, not recruiting
202 participants
Started: Aug 1, 2018 · Completed: Dec 30, 2023
1 condition6 sponsors1 location
NCT04287465
Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode
N/AActive, not recruiting
30 participants
Started: Aug 1, 2018 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03638375
TIL and Anti-PD1 in Metastatic Melanoma
PHASE1/PHASE2Active, not recruiting
34 participants
Started: Jul 31, 2018 · Completed: Nov 29, 2025
3 conditions2 sponsors1 location
NCT03540420
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
PHASE2Active, not recruiting
212 participants
Started: Jul 31, 2018 · Completed: Apr 1, 2027
1 condition45 sponsors41 locations
NCT03523416
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
NAActive, not recruiting
71 participants
Started: Jul 31, 2018 · Completed: Nov 30, 2028
1 condition1 sponsor15 locations
NCT03927768
Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)
N/AActive, not recruiting
264 participants
Started: Jul 31, 2018 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT03599765
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
PHASE2Active, not recruiting
380 participants
Started: Jul 31, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors12 locations
NCT03431935
Predictors and Outcomes in Patients With Sickle Cell Disease
N/AActive, not recruiting
94 participants
Started: Jul 31, 2018 · Completed: Jan 31, 2026
1 condition4 sponsors2 locations
NCT02454907
The Use of Technology to Improve MS Clinical Trials and Patient Care
NAActive, not recruiting
150 participants
Started: Jul 31, 2018 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT03433469
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
PHASE2Active, not recruiting
27 participants
Started: Jul 31, 2018 · Completed: Oct 31, 2026
7 conditions2 sponsors3 locations
NCT03543098
STaR Trial: Multiple Ligament Knee Injuries
NAActive, not recruiting
690 participants
Started: Jul 31, 2018 · Completed: Jun 30, 2027
2 conditions31 sponsors1 location
NCT03504241
Tolerance by Engaging Antigen During Cellular Homeostasis
PHASE1Active, not recruiting
8 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2029
3 conditions4 sponsors1 location
NCT03412812
A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain Metastases
NAActive, not recruiting
13 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04862117
Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)
NAActive, not recruiting
14 participants
Started: Jul 28, 2018 · Completed: Dec 8, 2026
1 condition1 sponsor4 locations
NCT03168516
Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants
PHASE3Active, not recruiting
1,065 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor32 locations
NCT03630289
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
NAActive, not recruiting
12 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT03502668
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Jul 27, 2018 · Completed: Dec 1, 2025
1 condition1 sponsor29 locations
NCT03607422
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
PHASE3Active, not recruiting
912 participants
Started: Jul 27, 2018 · Completed: Nov 4, 2025
1 condition1 sponsor196 locations
NCT03568058
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
PHASE1Active, not recruiting
30 participants
Started: Jul 26, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03908788
Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy
NAActive, not recruiting
130 participants
Started: Jul 26, 2018 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT03500991
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
PHASE1Active, not recruiting
10 participants
Started: Jul 26, 2018 · Completed: Jul 26, 2039
9 conditions1 sponsor1 location
NCT03597165
Incidental Genomics
NAActive, not recruiting
289 participants
Started: Jul 25, 2018 · Completed: Oct 1, 2027
1 condition1 sponsor3 locations
NCT03285789
Dyslexics' Visual Attention Field
NAActive, not recruiting
1,460 participants
Started: Jul 25, 2018 · Completed: Oct 21, 2026
1 condition1 sponsor1 location
NCT03336606
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
PHASE1Active, not recruiting
35 participants
Started: Jul 25, 2018 · Completed: Dec 1, 2026
5 conditions3 sponsors1 location
NCT03654131
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
PHASE2Active, not recruiting
100 participants
Started: Jul 25, 2018 · Completed: Dec 3, 2029
2 conditions1 sponsor1 location
NCT03143322
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NAActive, not recruiting
168 participants
Started: Jul 24, 2018 · Completed: Jul 22, 2027
4 conditions1 sponsor28 locations
NCT03480776
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
PHASE2Active, not recruiting
117 participants
Started: Jul 24, 2018 · Completed: Sep 15, 2026
1 condition2 sponsors17 locations
NCT03573700
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Jul 24, 2018 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT03792867
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
NAActive, not recruiting
5 participants
Started: Jul 23, 2018 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT03492177
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
PHASE2Active, not recruiting
63 participants
Started: Jul 23, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor34 locations
NCT03686748
Two Point Discrimination
EARLY_PHASE1Active, not recruiting
60 participants
Started: Jul 21, 2018 · Completed: Jul 16, 2027
6 conditions1 sponsor1 location
NCT03439735
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC
PHASE2Active, not recruiting
45 participants
Started: Jul 20, 2018 · Completed: Nov 1, 2026
1 condition3 sponsors1 location
NCT03237780
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
PHASE2Active, not recruiting
72 participants
Started: Jul 20, 2018 · Completed: Jun 30, 2027
24 conditions1 sponsor21 locations
NCT03354390
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
PHASE1Active, not recruiting
17 participants
Started: Jul 20, 2018 · Completed: Mar 3, 2026
1 condition2 sponsors1 location
NCT03503630
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
PHASE2Active, not recruiting
44 participants
Started: Jul 20, 2018 · Completed: Jul 2, 2024
1 condition3 sponsors3 locations